Oxis International, Inc. (OTCBB: OXIS) is the premiere provider for the potent antioxidant, Ergothioneine. The best anti aging compound in the world.
The products include therapeutic nutraceutical products, cosmeceutical products and proprietary formulations and clinical products that are developed internally and/or out-licensed to biotech and pharmaceutical companies as drug candidates.
Oxis International,Inc focus on naturally occurring protective substances since they are more likely to be both safe and efficacious. The primary products incorporate and emphasize the multifaceted “super antioxidant” compound, L-¬Ergothioneine (“ERGO”), as a key component. They own several patents and pending applications related to ERGO that cover current and planned products relevant to the nutraceutical and cosmecuetical businesses.
Oxidative stress refers to the situations in which the body’s antioxidant and other defensive abilities to combat free radicals (a.k.a highly reactive species of oxygen and nitrogen) are overwhelmed and one’s normal healthy balance is either lost or severely compromised.
A number of peer reviewed scientific papers referenced indicate that ERGO is one of the most potent, multifaceted biological compounds with both appreciable antioxidant, anti-inflammatory, neuroprotective and other protective properties. ERGO acts by itself, or in combination with other natural compounds to improve the body’s own intrinsic defenses against oxidative stress.
Accordingly, Oxis is focusing its efforts on developing products that deliver the benefits of ERGO taken by itself and in combination with other elements that enhance various health protective systems.
BENEFITS OF ERGO
Some of the potential benefits of ERGO include its ability to:
• Conserve and maintain the levels of other antioxidants such as Vitamin E, Vitamin C and glutathione;
• Increase respiration and the oxidation of fat (possibly contributing to increased energy and exercise capacity);
• Protect mitochondria from damage (this is important because potentially damaging reactive oxygen species are generated when oxygen is normally metabolized in mitochondria,
• Reduce the damaging effects of environmental ultraviolet radiation (likely to be important in protecting the eyes against cataract producing oxidative injury);
• Neutralize increased oxidative stress by providing an ROS (reactive oxygen species) and RNS (reactive nitrogen species) scavenging capacity, a property that protects key molecules in the body; and,
• Protect against the effects of neurotoxins that are believed to have a casual role in the development and progression of cognitive decline.
Ergothioneine available in penny stocks , please read further in Oxis website
Get in touch with OXIS on their OXIS FACEBOOK , follow OXIS TWITTER and OXIS WEBSITE
No comments:
Post a Comment